Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis
← catalyst calendarSponsored by Bristol-Myers Squibb (industry) · BMY — their whole pipeline →.
Phase
Phase 3
Status
Active, not recruiting
Study type
Interventional
Design
Na · None · Treatment
Enrollment
1,466actual
Sites
302
Countries
Australia, Canada, China +17
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2019-08-12 | actual | When the study began enrolling |
| Primary completion | 2026-07-25 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-07-26 | estimated | The whole study's end, after follow-up |
| First posted | 2019-07-29 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-10-20 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Psoriasis
Interventions
- Drug: BMS-986165 — also filed as Deucravacitinib
- Drug: Placebo
Primary outcomes
what the primary-completion date above is the date OFIncidence of Adverse Events (AEs)
measured Up to 244 weeks
Incidence of Serious Adverse Events (SAEs)
measured Up to 244 weeks
Proportion of participants achieving a satisfactory humoral response: pneumococcus
measured At Week 4 post vaccination
Proportion of participants achieving a satisfactory humoral response: tetanus titers
measured At Week 4 post vaccination
Publications
- PMID 42563042 — linked by the registry
- PMID 40113724 — linked by the registry
- PMID 40066907 — linked by the registry
- PMID 39602111 — linked by the registry
Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.
Permalink · BMY's whole pipeline · Catalyst calendar · Every registered study · What changed